Video Latest - ecancer

Highlights from ASCO 2019

Asst. Prof Bishal Gyawali and Monique Biryiana

3 Jun 2019

Enzalutamide as treatment for men with mHSPC who have received testosterone suppression

Dr Christopher Sweeney - Dana-Farber Cancer Institute, Boston, USA

2 Jun 2019

Enzalutamide improves survival for men with metastatic hormone-sensitive prostate cancer

Dr Christopher Sweeney - Dana-Farber Cancer Institute, Boston, USA

2 Jun 2019

MONALEESA-7: Results from phase III trial looking at ribociclib as an addition to endocrine therapy in advanced breast cancer

Dr Sara A. Hurvitz - UCLA Jonsson Comprehensive Cancer Center, Los Angeles, USA

1 Jun 2019

Ribociclib and endocrine therapy improves survival for pre-menopausal women with advanced breast cancer

Dr Sara A. Hurvitz - UCLA Jonsson Comprehensive Cancer Center, Los Angeles, USA

1 Jun 2019

Comment: The use of CDK 4/6 inhibitors now translates to a significant survival benefit in breast cancer treatment

Dr Harold Burstein - Dana-Farber Cancer Institute, Boston, USA

1 Jun 2019

The value of surgery in ovarian cancer

Prof Christina Fotopoulou - Queen Charlotte's and Chelsea Hospital, London, UK

24 May 2019

Latest in ovarian cancer treatment

Dr Susana Banerjee - The Royal Marsden NHS Foundation Trust, London, UK

24 May 2019

Controversies in the management of prostate cancer

Prof Mach Roach III - University of California, San Francisco, USA

9 May 2019

Differences in hormone therapy for patients with advanced metastatic prostate cancer

Prof Axel Merseburger - University Hospital Schleswig-Holstein, Lübeck, Germany

9 May 2019

State of art in systemic management of nmCRPC

Prof Stéphane Oudard - Georges Pompidou Hospital, Paris, France

8 May 2019

EAU prostate cancer guidelines 2019: What changed and why?

Prof Nicolas Mottet - University Hospital St Etienne, St Etienne, France

8 May 2019

Video